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Adult stem cell-based therapeutic approaches for tissue regeneration have been proposed for several years. However, adult stem
cells are usually limited in number and diﬃcult to be expanded in vitro, and they usually tend to quickly lose their potency with
passages, as they diﬀerentiate and become senescent. Culturing stem cells under reduced oxygen tensions (below 21%) has been
proposed as a tool to increase cell proliferation, but many studies reported opposite eﬀects. In particular, cell response to
hypoxia seems to be very stem cell type speciﬁc. Nonetheless, it is clear that a major role in this process is played by the hypoxia
inducible factor (HIF), the master regulator of cell response to oxygen deprivation, which aﬀects cell metabolism and
diﬀerentiation. Herein, we report that a chemical activation of HIF in human tendon stem cells reduces their proliferation and
inhibits their diﬀerentiation in a reversible and dose-dependent manner. These results support the notion that hypoxia, by
activating HIF, plays a crucial role in preserving stem cells in an undiﬀerentiated state in the “hypoxic niches” present in the
tissue in which they reside before migrating in more oxygenated areas to heal a damaged tissue.
1. Introduction
Stem cell-based therapies have promised to be an attractive
approach in tissue regeneration, especially with the discovery
that adult tissues possess a reservoir of progenitor cells that
can be isolated and cultured in vitro [1]. However, one of
the main obstacles that have been encountered is the
relatively small number of adult stem cells present in tissues
and their very limited proliferative capacity. Moreover, while
stem cells can be easily isolated from patients, they usually
tend to quickly lose their potency in vitro with passages, as
they diﬀerentiate and become senescent. A possible approach
to overcome these limitations is to culture cells under low
oxygen levels (below 21%) [2–5]. However, maintaining the
correct in vitro culturing conditions under reduced oxygen
tensions is quite complex. In fact, it requires special hypoxic
chambers to avoid subjecting cells to continuous hypoxia/
reoxygenation cycles during medium changes. Moreover,
results are often conﬂicting, as many authors reported both
the inhibition and promotion of cell proliferation even under
moderate hypoxia (5–10%) [6–9]. Clearly, one confounding
element is that adult stem cells are a very heterogeneous class
of diﬀerent cell subtypes, which are tissue speciﬁc. In
addition, isolation techniques and culturing conditions
in vitro heavily aﬀect their phenotype. Therefore, we can
speculate that these inconsistencies in the literature are likely
due to a distinct response of each stem cell subtype to
hypoxia. Nonetheless, under reduced oxygen tensions, it is
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well established that the alpha subunit of the hypoxia
inducible factor (HIF-1α) is stabilized [10], and this causes
a signaling cascade greatly aﬀecting stem cell metabolism
and diﬀerentiation [11–14] (Figure 1(a)). One interesting
feature of HIF mechanism of activation is that its stabiliza-
tion relies on the inhibition of a family of prolyl hydroxylases
(PHDs) that require oxygen to work; thus, their activity is
reduced under oxygen starvation (Figure 1(b)). Interestingly,
it has been shown that a chemical inhibition of PHD activity,
using for instance 2-oxoglutarate analogous like dimethylox-
alylglycine (DMOG), can mimic the eﬀects of hypoxia in
activating HIF even under normal oxygen tension
(Figure 1(c)). Therefore, it could be envisioned to add these
inhibitors in the culture medium to ﬁnely modulate stem cell
proliferation and diﬀerentiation, avoiding the complex
control of the oxygen tension.
On these bases, in this work, we studied the eﬀects of
HIF-1α stabilization, obtained by chemically inhibiting the
PHDs, on human tendon stem cells, that we recently
isolated for the ﬁrst time from the human rotator cuﬀ
tendons [15, 16].
2. Methods
2.1. Cell Isolation and Culture. Human tendon stem cells
(hTSCs) were isolated from supraspinatus tendon specimens
collected during arthroscopic rotator cuﬀ repair, according to
a previously reported procedure [15]. The protocol study was
approved by the Hospital Ethical Committee with authoriza-
tion number 2642 (Sept. 19, 2011). Samples from supraspina-
tus tendons (4–8mm wide) were collected from 6 patients
after signed informed consent, kept in HypoThermosol
(BioLife Solutions) at 4°C, and processed separately within
24 h, according to the procedure described below. Samples
were washed with phosphate-buﬀered saline (PBS) (Euro-
clone), cut into small pieces, and digested for 90min with
collagenase type I (3mg/mL; Worthington) and dispase
(4mg/mL; Gibco, Life Technologies) in PBS at 37°C. After
centrifugation, cell pellets were resuspended in the following
culture medium: α-Minimal Essential Medium (α-MEM)
(Sigma-Aldrich) supplemented with 2mM glutamine
(Euroclone), 1% antibiotic-antimycotic mixture (Euroclone),
and 20% (v/v) fetal bovine serum (FBS) (HyClone, Thermo
Fisher Scientiﬁc). Cells were then ﬁltered with a cell strainer
(70mM; BD Falcon) and plated in 150 cm2 dishes. Adherent
cells were cultured at 37°C in a humidiﬁed atmosphere of 5%
CO2. The medium was changed every 2-3 days. All experi-
ments were carried out with cells at passage four to six after
isolation [17].
2.2. Flow Cytometric Analysis. hTSCs were detached and
collected in PBS at a concentration of 2× 106 cells/mL.
Speciﬁc binding sites were blocked with a blocking solution
(50% 1X PSB, 50% FBS) for 30 minutes at room temperature
(RT). Cells were stained with antibodies against human: PE-
conjugated CD105, PE-conjugated CD90, FITC-conjugated
CD73, conjugated CD45, PerCP-eFluor 710-conjugated
CD34, and FITC-conjugated HLA-DR, for 10 minutes at
4°C. The respective isotype antibodies were used as controls.
Cell samples were analyzed with a Navios ﬂow cytometer
(Beckman Coulter) equipped with Kaluza software
(Beckman Coulter).
2.3. Chemical Activation of HIF-1α with DMOG. DMOG was
prepared by solubilization in H2O, as suggested by the
manufacturer’s protocol (Sigma Aldrich). Twenty-four hours
after seeding, cells were either cultured for 96 h in normal
growth medium with diﬀerent concentrations of DMOG
(0.01mM, 0.1mM, and 1mM) or in normal growth medium
without DMOG (controls). The medium was changed every
48 h in all experiments unless speciﬁed. To study the
reversibility of the eﬀects of DMOG on cell viability and
proliferation capacity, multilineage diﬀerentiation potential
of hTSCs was tested upon DMOG removal from the culture
medium. To this purpose, cells were ﬁrst cultured in the
presence of diﬀerent concentrations of DMOG for 96 h, as
described above, washed twice with PBS, detached, and then
reseeded and grown in normal medium without DMOG.
2.4. Western Blot Analysis. Control hTSCs or treated with
diﬀerent concentrations of DMOG for 96h were rinsed twice
with cold PBS, harvested, and lysed in RIPA buﬀer contain-
ing protease and phosphatase inhibitors. Protein concentra-
tions were measured by the Pierce™ BCA Protein Assay Kit
(Thermo Fisher Scientiﬁc), following the manufacturer’s
protocol. Proteins (30μg) were denatured by boiling for
5min in sample buﬀer (6.5mM Tris-HCl, pH6.8, 2% SDS
(w/v), 10% glycerol (v/v), 5% 2-mercaptoethanol (w/v), and
0.01% bromophenol blue (w/v)) and separated on a 10%
polyacrylamide gel in denaturing conditions. Proteins were
subsequently transferred into nitrocellulose membranes by
electroblotting using 100 volts for 2 hours. Then, the
membranes were incubated overnight in Tris-buﬀered saline
(TBS: 10mM Tris-HCl, pH7.4, 150mM NaCl), 0.1% (v/v)
Tween 20 (TBS-Tween) containing 5% (w/v) dried milk or
5% (w/v) bovine serum albumin (BSA; Sigma-Aldrich) for
the blocking buﬀer. Blots were incubated with a primary
antibody speciﬁc for HIF-1α (Cell Signaling Technology)
diluted 1 : 1000 in the appropriate blocking solution for three
hours at room temperature. Membranes were then washed
four times for 10min with TBS-Tween and then incubated
with the appropriate secondary antibody horseradish perox-
idase (HRP) conjugated for 1 hour at room temperature.
After four washes in TBS-Tween, the protein bands were
detected using an ECL detection kit (Thermo Fisher Scien-
tiﬁc) as described by the manufacturer. Relative protein
expression levels were calculated normalizing data on Lamin
A/C, which was used as internal control.
2.5. Cell Morphology and Proliferation. Cells were plated at a
concentration of 2.6× 103 cells/cm2 and cultured in normal
growth medium in the presence of DMOG (0mM,
0.01mM, 0.1mM, and 1mM), as described above. Cell
morphology was examined with a phase-contrast microscope
(Axiovert 40 CFL, Zeiss, equipped with a Moticam 2300
camera, Motic) at each time point to assess the eﬀects of
DMOG treatment on hTSC phenotype. Cell growth curves
were prepared after harvesting with Trypsin-EDTA solution
2 Stem Cells International
(Sigma-Aldrich) by counting cells with a Countess Cell
Counter (Invitrogen, Life Technologies), according to the
manufacturer’s procedure. Cell viability was determined by
trypan blue dye exclusion assay. All assays were carried out
in triplicates for each sample.
2.6. Cell Viability by MTT Assay. hTSCs were plated in
12-well plates (1× 104 cells/well) and treated with diﬀerent
concentrations of DMOG or cultured in the growth medium
alone.At each timepoint (0, 24, 48, and 72h), twohours before
collection, the reconstituted 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl-2H-tetrazolium bromide (MTT) (5mg/mL in PBS;
Sigma-Aldrich) was added to the medium (10% of the ﬁnal
volume). Following a two-hour incubation at 37°C, cells were
lysed by adding an amount of MTT solubilization solution
equal to the original culture medium volume, gently pipetting
to completely dissolve the MTT formazan crystals. The MTT
reduction was spectrophotometrically measured at a wave-
length of 570nm.
2.7. Cell Viability Assay by RealTime-Glo™. Cell viability was
assessed using RealTime-Glo MT Cell Viability Assay
(Promega) after 48 and 96h of DMOG treatment (0mM,
0.01mM, 0.1mM, and 1mM) according to the manufac-
turer’s protocol. The luminescent signal was measured at 48
and 96 h using VICTOR X3™ Multilabel Plate Reader.
Brieﬂy, MT cell viability substrate and NanoLuc® enzyme
were both diluted 1 : 1000 in culture medium at a ﬁnal
volume of 100 μL per well. Cells were seeded at a density of
500 cells/well in a 96-well plate. Data were normalized to
the untreated control.
2.8. Cytotoxicity Assay by CellTox Method. CellTox™ cyto-
toxicity assay (Promega) was used to investigate the cytotoxic
eﬀect of DMOG treatment, as the assay measures changes in
membrane integrity that occur as a result of cell death.
Brieﬂy, cells were seeded in a 96-well plate at a concentration
of 500 cells/well and incubated for 48 and 96 h with DMOG
(0mM, 0.01mM, 0.1mM, and 1mM) and tested according
to manufacturer’s protocol. After each incubation, an equal
volume of 100μL of CellTox buﬀer containing 1 : 500 dilu-
tion CellTox Green Dye was added to each well and incu-
bated at room temperature for 15 minutes. The signal was
measured using the VICTOR™ X3 Multilabel Plate Reader
with an excitation wavelength of 485–500nm and emission
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Figure 1: Schematic representation of diﬀerent mechanisms of HIF-1α activation. The picture shows a schematic representation of (a) HIF-
1α degradation by proteasome under normoxic conditions, (b) HIF-1α stabilization under hypoxic conditions mediated by the oxygen
deprivation which causes the inhibition of PHD2 activity, and (c) chemical-induced HIF-1α stabilization under normoxic conditions by
the inhibition of PHD2 activity through DMOG treatment.
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ﬁlter of 520–530nm. Data were normalized to the untreated
control.
2.9. Cell Viability by Annexin V/PI Flow Cytometric Assay.
Cell viability was measured by ﬂow cytometry on cells cul-
tured for 96 h in normal growth medium with diﬀerent con-
centrations of DMOG (0, 0.01, 0.1, and 1mM) using
Annexin V-FITC Apoptosis Detection Kit (eBioscience),
according to the manufacturer’s protocol.
Brieﬂy, adherent cells were trypsinized, washed in PBS by
gentle shaking, and resuspended at the concentration of 5∗
105 cells/mL with 200 μL of a speciﬁc binding buﬀer
(10mM HEPES/NaOH, pH7.4; 140mM NaCl, and 2.5mM
CaCl2) containing 5 μL of Annexin V-FITC. After incubation
for 10min in the dark at room temperature, cells were
washed in PBS, resuspended in 190μL of binding buﬀer,
and then stained with 10 μL propidium iodide (20 μg/mL).
Samples were immediately acquired with a Navios Flow Cyt-
ometer (Beckman Coulter) and analyzed using Kaluza 1.2
software (Beckman Coulter).
2.10. RNA Extraction and Real-Time PCR. Total RNA was
isolated using TRIzol® Reagent (Ambion, Life Technologies),
and 1μg of extracted RNA was reverse transcribed to cDNA
using the iScript cDNA synthesis kit (BioRad), according to
the manufacturer’s instructions. Real-time PCR was per-
formed in a 96-well plate with 10 ng of cDNA as a template,
0.2μM primers, and 1x Power SYBR® Green PCR Master
Mix (Applied Biosystems, Life Technologies) in a 20μL ﬁnal
volume per well using a StepOnePlus™ Real-Time PCR Sys-
tem (Applied Biosystems). The mRNA levels of vascular
endothelial growth factor (VEGF), Nanog homeobox
(NANOG), octamer-binding transcription factor 4 (OCT4),
Kruppel-like factor 4 (KLF4), Tenascin C, collagen type I
alpha-1 (COL1A1), peroxisome proliferator-activated recep-
tor-γ (PPAR-γ), lipoprotein lipase (LPL), human alkaline
phosphatase (ALP), and SRY-box9 (SOX9) were assessed.
Ribosomal protein S14 (S14) was used as the housekeeping
gene in all quantitative analyses (Table 1).
Ampliﬁcation protocol: initial denaturation at 95°C for 3
minutes followed by 40 cycles of 5 seconds each at 95°C and
30 seconds at 57°C. Relative quantiﬁcation of target genes
was performed in triplicates, analyzed using the 2−ΔΔCt
method and normalized to the corresponding S14 values.
2.11. Adipogenic Diﬀerentiation. Cells were plated at a con-
centration of 3× 104 cells/cm2 and cultured in DMEM-low
glucose (Sigma-Aldrich), 10% FBS (HyClone, Thermo Fisher
Scientiﬁc), 4mML-glutamine (Euroclone), and1%antibiotic-
antimycotic mixture (Euroclone), with the addition of the
mesenchymal stem cell adipogenesis kit (Millipore) for 21
days, according to themanufacturer’s instructions. The adipo-
genicmediumwas changed every other day.At day 21,Oil Red
O solution (Millipore) was used to stain lipid droplets of
derived adipocytes, according to the manufacturer’s proce-
dures. All photomicrographs were acquired with an Axiovert
40 microscope (Zeiss) equipped with aMoticam 2300 camera
(Motic).ThemRNAexpressionof adipogenicmarkers includ-
ing PPAR-γ and LPL were also assessed on days 7 and 21 by
real-time PCR, as described above [17].
2.12. Osteogenic Diﬀerentiation. Cells were plated at the con-
centration of 3× 104 cells/cm2 and cultured in the osteogen-
esis induction medium, which was constituted of DMEM-
low glucose (Sigma-Aldrich), 10% FBS (HyClone, Thermo
Fisher Scientiﬁc), 4mM L-glutamine (Euroclone), and 1%
antibiotic-antimycotic mixture (Euroclone), supplemented
with 0.1μM dexamethasone, 50μg/mL L-ascorbic acid-2-
phosphate, and 10mM β-glycerophosphate (all reagents
from Sigma-Aldrich) for 17 days. The osteogenic medium
was changed every other day. At day 17, Alizarin Red
solution (Millipore) was used to detect calcium deposition
in derived osteoblasts, according to the manufacturer’s
instruction. All photomicrographs were acquired with an
Axiovert 40 microscope (Zeiss) equipped with a Moticam
2300 camera (Motic). The expression of osteogenic marker
ALP was determined by real-time PCR on days 5 and 17, as
described above [17].
2.13. Chondrogenic Diﬀerentiation. Chondrogenic diﬀerenti-
ation was performed using StemPro Chondrogenesis
Diﬀerentiation Kit (Life Technologies), according to the
manufacturer’s instruction. Brieﬂy, cells were resuspended
Table 1
Gene Primer sequence
S14
Fw: 5′-GTGTGACTGGTGGGATGAAGG-3′
Rev: 5′-TTGATGTGTAGGGCGGTGATAC-3′
VEGF
Fw: 5′-CAACATCACCATGCAGATTATGC-3′
Rev: 5′-TCGGCTTGTCACATTTTTCTTGT-3′
NANOG
Fw: 5′-GGTCCCAGTCAAGAAACAGA-3′
Rev: 5′-GAGGTTCAGGATGTTGGAGA-3′
OCT4
Fw: 5′-AGGAGAAGCTGGAGCAAAA-3′
Rev: 5′-GGTCGAATACCTTCCCAAA-3′
KLF4
Fw: 5′-GACTTCCCCCAGTGCTTC-3′
Rev: 5′-CGTTGAACTCCTCGGTCTC-3′
Tenascin C
Fw: 5′-CGGGGCTATAGAACACCAGT-3′
Rev: 5′-AACATTTAAGTTTCCAATTTCAGGTT-3′
COL1A1
Fw: 5′-GGGATTCCCTGGACCTAAAG-3′
Rev: 5′-GGAACACCTCGCTCTCCA-3′
PPAR-γ
Fw: 5′-TTCCTTCACTGATACACTGTCTGC-3′
Rev: 5′-GGAGTGGGAGTGGTCTTCCATTAC-3′
LPL
Fw: 5′-AGAGAGAACCAGACTCCAATG-3′
Rev: 5′-GGCTCCAAGGCTGTATCC-3′
ALP
Fw: 5′-CGCACGGAACTCCTGACC-3′
Rev: 5′-GCCACCACCACCATCTCG-3′
SOX9
Fw: 5′-GTACCCGCACTTGCACAAC-3′
Rev: 5′-TCGCTCTCGTTCAGAAGTCTC-3′
4 Stem Cells International
in growth medium at the concentration of 1.6× 107, and 5μL
droplets were seeded in the center of a multiwell plate wells.
After two hours, the chondrogenesis induction medium pro-
vided by the kit was added. The chondrogenic medium was
changed every 2-3 days for 14 days. Alcian blue solution
(Bio-Optica) was used to stain acid mucopolysaccharides
formed during the diﬀerentiation process. The expression
of chondrogenic marker SOX9 was determined by real-time
PCR on days 5 and 14, as described above [17].
2.14. Statistical Analysis. Statistical analysis was performed
using GraphPad Prism v 6.0 software (GraphPad Software
Inc.). Data were typical results from three replicate experi-
ments for each of the six patient-derived cell lines and were
expressed as the mean± standard deviation (SD). The
Shapiro-Wilk normality test was used to evaluate the normal
distribution of the sample.
One-way analysis of variance (ANOVA), followed by
two-tailed, paired Student’s t-test or Mann–Whitney test
according to the characteristics of the data distribution,
wherever applicable, was used for multiple comparisons. Lin-
ear contrasts were used to assess for changes in the mean
values with increasing doses of DMOG. The signiﬁcance level
was set at p value lower than 0.05.
3. Results
3.1. Eﬀects of DMOG on HIF-1α Stabilization on hTSCs. To
chemically activate HIF-1α, hTSCs were cultured under nor-
moxia in the presence of DMOG at diﬀerent concentrations
(0.01mM, 0.1mM, and 1mM) for 96 h and compared to
control cells that were cultured in normal growth medium
without DMOG (Figure 2). Analysis of HIF-1α nuclear local-
ization by Western blot revealed that the factor was activated
by DMOG in a dose-dependent manner (Figure 2(a)). Simi-
larly, analysis of VEGF, one of the main HIF-1α target genes,
showed an expression increase by real-time PCR that was
proportional to the concentration of DMOG in the culture
medium (Figure 2(b)). Cell morphology analysis by phase-
contrast microscopy revealed no noticeable diﬀerences
between control and DMOG-treated hTSCs (Figure 3(a),
96 h of DMOG treatment). However, DMOG at 1mM con-
centration induced cell suﬀering, as the formation of vacuoles
and cell proliferation arrest could be observed throughout the
culture plate (Figure 3(a)). The evaluation of the eﬀects of
DMOG on cell proliferation revealed a slight, although not
statistically signiﬁcant, increase when cells were treated with
0.01mM DMOG (Figure 3(b)). On the other hand, a dose-
dependent reduction could be initially observed at 0.1mM
after 72h of treatment, reaching a signiﬁcant decrease of
51%, 72.6%, and 77.7% in the presence of 1mM DMOG at
48, 72, and 96 h, respectively, as compared to control cells
(Figure 3(b)). These results were conﬁrmed byMTT cell met-
abolic activity assay where a DMOG dose-dependent reduc-
tion could be observed at all time points (24, 48, and 72 h),
reaching a 53.1% reduction at 1mM, as compared to control
cells (Figure 3(c)). Similarly, RealTime-Glo™ cell viability
tests showed a DMOG dose-dependent signal reduction,
with the exception of 0.01mM DMOG that showed a signif-
icant increase at 96 h as compared to control cells
(Figure 3(d)). Cell toxicity tests revealed no signiﬁcant diﬀer-
ences at all DMOG concentrations at 48 and 96 h, with the
exception of 0.01mM DMOG that showed a minor, yet sta-
tistically signiﬁcant, decrease in cell toxicity at 96 h. Cell
death analysis by Annexin V test revealed no signiﬁcant cell
apoptosis at all tested DMOG concentrations (Figure 3(f)).
3.2. Eﬀects of HIF-1α Stabilization on hTSC Stemness. To
evaluate the eﬀects of DMOG on hTSC stemness, the expres-
sion of stem cell markers NANOG, OCT4, and KLF4 was
determined by real-time PCR after a 96 h DMOG treatment
at 0.01mM, 0.1mM, and 1mM and compared to those of
control cells (Figure 4(a)). The results showed a statistically
signiﬁcant trend increase of the mRNA levels of NANOG,
OCT4, and KLF4, as compared to control cells, and that it
was proportional to the concentration of DMOG used (red
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Figure 2: HIF-1α chemical activation with DMOG. HIF-1α expression was analyzed by Western blot (a). The activation of HIF-1α was also
analyzed measuring the expression of VEGF by real-time PCR (b). Western blots were quantiﬁed by densitometry and results expressed with
arbitrary units. Real-time PCR data are expressed as fold change as compared to control cells without DMOG treatment. p values were
calculated using Student’s t-test. Only p values< 0.05 are indicated: ∗p < 0 05, ∗∗p < 0 01, and ∗∗∗p < 0 001.
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Figure 3: Eﬀects of HIF-1α activation on hTSC morphology, proliferation, and viability. (a) Phase-contrast microphotographs (original
magniﬁcation ×10), (b) cell growth curves, (c) MTT assay, (d) RealTime-Glo assay, (e) CellTox assay, and (f) Annexin V/PI staining of
hTSCs during a 96 h treatment with diﬀerent concentrations of DMOG (0.01mM, 0.1mM, and 1mM) in normal growth medium and
compared to control cells cultured without DMOG (0mM). All experiments were performed in triplicates. Error bars show the mean± SD
of six and three diﬀerent experiments in the case of cell growth curves and MTT assay, respectively. p values were calculated using
Student’s t-test. Only p values< 0.05 are indicated: ∗p < 0 05, ∗∗p < 0 01, ∗∗∗p < 0 001, and ∗∗∗∗p < 0 0001, as compared to control cells.
Bar = 100 μm.
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tendency line, Figure 4(a)). The mRNA levels of Tenascin C
and COL1A1 tendon markers were measured by real-time
PCR in hTSCs exposed to diﬀerent concentrations
(0.01mM, 0.1mM, and 1mM) of DMOG for 96 h. The
results showed a statistically signiﬁcant trend decrease of
the mRNA levels of both tendon markers, which was propor-
tional to the concentration of DMOG used (red tendency
line, Figure 4(b)). In particular, the expression of both
Tenascin C and COL1A1 showed a slight, although not sig-
niﬁcant, increase when cells were treated with 0.01mM
DMOG, as compared to control cells. On the other hand, a
signiﬁcant reduction, which was concentration dependent,
could be observed at 0.1mM and 1mM DMOG, reaching
an 8.1- and 2.1-fold decrease for Tenascin C and COL1A1,
respectively, at 1mM DMOG concentration (Figure 4(b)).
3.3. Eﬀects of HIF-1α Stabilization on hTSC Diﬀerentiation.
To assess the eﬀects of HIF-1α activation on the multipo-
tency of hTSCs, cells were induced to diﬀerentiate toward
osteoblasts, adipocytes, and chondroblasts by culturing them
in the appropriate diﬀerentiation medium for 17, 21, and 28
days, respectively, in the presence of DMOG at diﬀerent
concentrations (0, 0.01, 0.1, and 1mM), as described in the
Methods (Figure 5). The adipogenic diﬀerentiation was qual-
itatively evaluated by Oil Red O staining revealing a reduc-
tion in the amount of lipid intracellular droplets, which was
proportional to the amount of DMOG in the culture medium
(Figure 5, left column). The osteogenic diﬀerentiation was
assessed qualitatively by Alizarin Red S staining, which
showed that the amount of calcium deposits was markedly
reduced, in a dose-dependent manner, when cells were cul-
tured in the presence of DMOG, as compared to control cells
(Figure 5, central column). The chondrogenic diﬀerentiation
was assessed qualitatively by Alcian blue staining, showing a
deposition of extracellular matrix proteins when cells were
cultured in the presence of DMOG, especially at 1mM, as
compared to control cells (Figure 5, right column). The
eﬀects of HIF-1α activation on adipogenesis and osteogenesis
were also analyzed quantitatively by determining the mRNA
levels of adipogenic markers PPAR-γ and LPL, osteogenic
marker ALP, and chondrogenic marker SOX9 by real-time
PCR (Figure 6). The results showed a signiﬁcant decrease of
all markers that was proportional to the concentration of
DMOG used (Figure 6). In particular, PPAR-γ showed 2.8-,
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Figure 4: Eﬀects of HIF-1α activation on stem cell and tendon marker expression. (a) Gene expression of NANOG, OCT4, and KLF4 by real-
time PCR after a 96 h DMOG treatment, as compared to control-untreated cells. (b) Gene expression of Tenascin C and COL1A1 by real-time
PCR after a 96 h DMOG treatment, as compared to control-untreated cells. Values are expressed as fold changes relative to control cells. Data
are expressed as means± SD of six diﬀerent experiments. One-way ANOVA was used to test for diﬀerences among DMOG-treated cell
groups. Bonferroni post hoc test was performed to compare individual DMOG-treated group cells against each other to see where the
signiﬁcant diﬀerences lie. Linear contrast analysis (analysis of variance) was used to assess for changes in the mean values with increasing
doses of DMOG (red lines). Only p values< 0.05 are indicated: ∗p < 0 05, ∗∗p < 0 01, and ∗∗∗∗p < 0 0001, as compared to control cells.
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31.7-, and 59.7-fold expression decrease, while LPL showed
2.3-, 10.1-, and 109.2-fold decrease for 0.01mM, 0.1mM,
and 1mM DMOG treatment, as compared to control cells,
respectively (Figure 6). Osteogenic diﬀerentiation in the
presence of DMOG was inhibited, as revealed by a signiﬁcant
ALP decrease that was proportional to the concentration of
DMOG used (Figure 6). In particular, ALP showed 3.7-,
15.1-, and 386-fold decrease when cells were incubated with
0.01mM, 0.1mM, and 1mM DMOG, respectively, as com-
pared to control cells (Figure 6).
Finally, it was tested whether the eﬀects of HIF-1α activa-
tion could be reverted. To this purpose, hTSCs were grown in
the presence of 0.01mM, 0.1mM, and 1mM DMOG for
96 h, harvested, replated at the same cell concentration, and
then cultured in normal growth medium (Figure 7(a)). Cells
were then harvested and counted every 24 h for 4 days,
starting 24 h after seeding. Cell growth analyses revealed that
cells pretreated with 0.01mM and 0.1mM DMOG could
regain the normal proliferation capacity, analogous to con-
trol cells, when switched back to the normal growth medium
(Figure 7(b)). On the other hand, cells treated with 1mM
DMOG did not completely recover from DMOG treatment,
at least within the experiment timeframe, as they showed a
markedly proliferation reduction at 72h, reaching 58.4%
decrease at 96 h, as compared to control cells (Figure 7(b)).
MTT assays conﬁrmed cell growth experiments, revealing
that DMOG treatment eﬀects could be reverted within 72 h
after switching cells in normal growth medium, with the
exception of 1mM DMOG, that still showed a signiﬁcant
reduction (about 36.2% at 72 h), as compared to control cells
(Figure 7(c)). Then, the reversibility of the eﬀects of HIF-1α
activation on cell diﬀerentiation was determined. To this
purpose, cells were ﬁrst pretreated for 96h with DMOG,
followed by 96 h in normal growth medium to reestablish
normal proliferation, and then diﬀerentiated in DMOG-free
medium. Analysis of the adipogenic, osteogenic, and chon-
drogenic diﬀerentiation markers revealed no signiﬁcant dif-
ference between DMOG pretreated and control cells at all
concentrations (p > 0 05) (Figures 7(c) and 7(d)).
4. Discussion
Adult stem cells have been found to reside in hypoxic tissue
compartments often referred to as “stem cell niches.”
Although the microenvironment and the molecular signals
present in the niches have been only partially elucidated, it
is now accepted that a low-oxygen tension helps to maintain
the undiﬀerentiated state of the progenitor cells [18, 19].
Moreover, it has been shown that culturing stem cells
in vitro in low-oxygen incubators mimics the “niche,” at least
partially and cells seem to maintain their potency without
diﬀerentiating [18, 20]. However, as already reported in the
Introduction, the eﬀects of low oxygen on adult stem cells
appear to be very variable and cell subtype dependent, and
it has been also reported that it can reduce stem cell prolifer-
ation and favor diﬀerentiation. Clearly, ﬁnding a way of
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Figure 5: Eﬀects of HIF-1α activation on in vitro diﬀerentiation of hTSCs toward the adipogenic, osteogenic, and chondrogenic phenotypes.
Adipogenic, osteogenic, and chondrogenic diﬀerentiation ability of hTSCs in the presence of DMOG at diﬀerent concentrations (0mM,
0.01mM, 0.1mM, and 1mM) in the appropriate diﬀerentiation medium was qualitatively evaluated by (a) Oil Red O, (b) Alizarin Red S
staining, and (c) Alcian blue staining, respectively. (a) Lipid intracellular droplets (red) in the adipocytes were stained with Oil Red O
solution. (b) Alizarin Red S staining revealed the presence of calcium deposits (yellowish-brown). (c) Alcian blue staining was used to
stain acid mucopolysaccharides formed during the diﬀerentiation process. Typical results are shown. Original magniﬁcation ×10.
Bar = 100 μm.
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amplifying stem cells without compromising their potency is
vital for reaching the cell numbers needed for their therapeu-
tic application. Along this line, the use of hypoxic incubators
has been shown to be feasible, and the possibility of pharma-
cologically mimic oxygen deprivation represents a simpler
and cost-eﬀective alternative. Chemically mimicking the
hypoxic niche has several advantages over culturing cells in
low oxygen: (a) a drug can be easily synthesized on a large
scale, (b) the methodology does not require especially
designed and expensive incubators, (c) the drug dosage can
be easily adjusted and controlled, and (d) the treatment can
be suspended at any time. On the other hand, controlling
the oxygen tension can be very cumbersome, especially when
cells are cultured for a prolonged time and the media needs to
be replaced without exposing cells to normal-oxygen tension.
This can be achieved only with specially designed and expen-
sive culturing chambers, which are not commonly used in
most laboratories or research hospitals. Actually, most stud-
ies under hypoxic conditions are performed with normal
incubators connected to a nitrogen tank; thus, cells are
constantly exposed to cycles of low/high oxygen. This unfor-
tunately mimics the ischemia/reperfusion conditions that
might be detrimental for maintaining stem cells, as they
could stimulate their diﬀerentiation, as it happens, for
instance, after a cardiac infarct [21].
On these bases, with so many conﬂicting results, it is very
hard to come up with a general picture. However, it is clear
that under oxygen deprivation, any stem cell activates a com-
mon response mechanism, which is mainly regulated by the
hypoxia-inducible factor. In particular, HIF-1α, which is acti-
vated under low-oxygen tension, has been shown to play a
pivotal role in stem cell diﬀerentiation [11, 18]. In particular,
the activation of HIF-1α has been shown to inhibit stem cell
diﬀerentiation [3, 22]. Moreover, activation of HIF-1α is
known to enhance the cell defense machinery against apo-
ptosis [23–26]. This is another crucial issue in stem cell ther-
apy, as most injected cells usually die because they have to
survive in a very hostile environment while trying to reach
the damaged tissue. Indeed, preconditioning stem cells by
activating HIF-1α has been shown to increase their survival
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Figure 6: Quantitative evaluation of the eﬀects of HIF-1α activation on in vitro diﬀerentiation of hTSCs toward the adipogenic, osteogenic,
and chondrogenic phenotypes. Peroxisome proliferator-activated receptor-γ (PPAR-γ), lipoprotein lipase (LPL), and human alkaline
phosphatase (ALP) expression by real-time PCR in hTSCs induced to diﬀerentiate toward adipocytes, osteoblasts, and chondroblasts in
the presence of diﬀerent concentrations of DMOG (0.01mM, 0.1mM, and 1mM). Control cells were cultured under the same conditions
but without DMOG. Values are expressed as fold changes relative to control cells. Data are expressed as the mean± SD of three diﬀerent
experiments. p values were calculated using Student’s t-test. Only p values< 0.05 are indicated: ∗p < 0 05, ∗∗p < 0 01, ∗∗∗p < 0 001,
and ∗∗∗∗p < 0 0001, as compared to control cells.
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after injection and ultimately obtain better regenerative
results [27, 28]. Thus, in this study, we tested the eﬀects of
HIF-1α activation on human adult tendon stem cells, which
we recently isolated from the rotator cuﬀ supraspinatus ten-
don [15]. This tissue is quite hypoxic, as it is poorly
vascularized in the adults, and this could explain, at least
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Figure 7: Reversibility of HIF-1α activation eﬀects on hTSC proliferation, viability, and diﬀerentiation markers. (a) Schematic representation
of the experimental setup. hTSCs were cultured in the presence of diﬀerent concentrations of DMOG (0mM, 0.01mM, 0.1mM, and 1mM) in
normal growth medium for 96 h, washed with PBS, detached, replaced at the same concentration in normal growth medium without DMOG,
and then left overnight before successive analyses at 24, 48, 72, and 96 h after seeding. (b) Cell growth curves and (c) MTT assay of hTSCs after
culturing DMOG-pretreated cells for 96 h in DMOG-free medium normal and compared to control cells (0mM DMOG). (d) Peroxisome
proliferator-activated receptor-γ (PPAR-γ), lipoprotein lipase (LPL), and human alkaline phosphatase (ALP) expression by real-time PCR
in hTSCs induced to diﬀerentiate toward adipocytes, osteoblasts, and chondroblasts after a 96 h preconditioning with DMOG, followed by
96 h in normal DMOG-free growth medium, and then diﬀerentiation in DMOG-free medium. Control cells were cultured under the same
conditions but without DMOG. Values are expressed as fold changes relative to control cells. All experiments were performed in
triplicates. Data are expressed as the mean± SD of six in the case of cell growth curves and three diﬀerent experiments in case of MTT
assay and diﬀerentiation marker expression. p values were calculated using Student’s t-test. Only p values< 0.05 are indicated: ∗p < 0 05,
as compared to control cells.
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partially, its limited healing capacity. To have a better control
on HIF-1α activation, we decided to modulate it with a phar-
macological approach using DMOG at diﬀerent concentra-
tions, which allowed to easily ﬁne-tune HIF-1α expression.
As we anticipated, in this study, we found that tendon stem
cells cultured in the presence of DMOG reduce their prolifer-
ation capability and the eﬀect is proportional to the concen-
tration used. This is in agreement with other reports on adult
stem cells cultured under hypoxia [29, 30]. Actually, a ten-
dency, although not signiﬁcant, toward a proliferation
increase could be observed at very low DMOG concentration
(0.01mM), which is also in agreement with other literature
reports, showing that moderate hypoxia can stimulate stem
cell proliferation, while extreme hypoxia induces them to
exit the cell cycle and enter a quiescent state [9]. Nonethe-
less, we found that DMOG eﬀects on cell proliferation are
reversible, as cells could regain their proliferation capability
once the molecule is removed from the culture medium.
We also found that stem cell markers NANOG, OCT4,
and KLF4 are slightly upregulated upon DMOG supple-
mentation and this increase is proportional to the DMOG
concentration used. Moreover, tendon-speciﬁc markers
decrease during DMOG treatment, supporting the notion
that chemically induced hypoxia can keep stem cells into
a more undiﬀerentiated state. Furthermore, DMOG eﬀects
on tendon stem cell diﬀerentiation toward osteoblasts and
adipocytes were also assessed. The results showed that dif-
ferentiation is hindered when HIF-1α is activated in the
presence of DMOG and that the inhibition is proportional
to the concentration of DMOG used, supporting the
notion that stem cells reside in the tissue in hypoxic
niches, where HIF-1α is activated and the diﬀerentiation
is inhibited, until cells migrate to more oxygenated areas.
Actually, the literature on this issue is quite controversial.
In fact, while some reports show a direct increase in the
diﬀerentiation markers upon in vitro diﬀerentiation of
hypoxia-activated mesenchymal stem cells [29, 31–34],
other reports showed a marked reduction of diﬀerentiation
[3, 18, 22, 30, 35–40]. Indeed, while the general notion is
that a more primitive stem cell should give better regener-
ative results, it could be argued that a more committed
stem cell is more prone to diﬀerentiate than an immature
one, especially when diﬀerent stem cell progenitors are
compared in the same diﬀerentiation timeframe. In fact,
at this stage, we cannot exclude that DMOG pretreated
cells, as they show a higher expression of stem cell
markers, could be more eﬀective in regenerating damaged
tissue in vivo.
5. Conclusions
In conclusion, in this study, we found that a chemical activa-
tion of HIF-1α reduces human tendon stem cell proliferation,
increases the expression of stem cell markers, and reduces
their commitment toward the tendon phenotype. These
eﬀects are reversible upon DMOG removal from the culture
medium. Moreover, DMOG present in the diﬀerentiation
medium reversibly inhibits stem cell diﬀerentiation. Further
studies to test whether DMOG pretreatment has any
beneﬁcial eﬀects in vivo in tendon stem cell regeneration
capacity are currently undergoing in our laboratories.
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